These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

126 related items for PubMed ID: 11601208

  • 1. [Experimental study of cord blood plasma enhancing the anti-leukemia effect of Ara-C].
    Zhang X, Chen Y, Wang X.
    Zhonghua Xue Ye Xue Za Zhi; 1999 May; 20(5):229-31. PubMed ID: 11601208
    [Abstract] [Full Text] [Related]

  • 2. Effects of mast cell growth factor on Ara-C mediated acute myeloid leukemia cell killing.
    Tafuri A, De Felice L, Mascolo MG, Valentini T, Petrucci MT, Petti MC.
    Stem Cells; 1993 Jul; 11 Suppl 2():88-92. PubMed ID: 7691332
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Hematopoietic growth factor stimulation and cytarabine cytotoxicity in vitro: effects in untreated and relapsed or primary refractory acute myeloid leukemia cells.
    te Boekhorst PA, Löwenberg B, Sonneveld P.
    Leukemia; 1994 Sep; 8(9):1480-6. PubMed ID: 7522289
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. [Mobilization of autologous peripheral blood stem cells by cytosine arabinoside combined with recombinant human granulocyte colony-stimulating factor].
    Shi Y, Han X, He X, Yang J, Liu P.
    Zhonghua Yi Xue Za Zhi; 2002 Apr 10; 82(7):462-6. PubMed ID: 12133516
    [Abstract] [Full Text] [Related]

  • 8. Human stem cell factor-antibody [anti-SCF] enhances chemotherapy cytotoxicity in human CD34+ resistant myeloid leukaemia cells.
    Lu C, Hassan HT.
    Leuk Res; 2006 Mar 10; 30(3):296-302. PubMed ID: 16112192
    [Abstract] [Full Text] [Related]

  • 9. [Detection of the resistance to Ara-C blast cells in acute myeloid leukemia using flow cytometry].
    Lacombe F, Belloc F, Dumain P, Puntous M, Cony-Makhoul P, Bernard P, Boisseau MR, Reiffers J.
    Bull Cancer; 1995 Mar 10; 82(5):349-56. PubMed ID: 7626842
    [Abstract] [Full Text] [Related]

  • 10. Modulation of in vitro chemosensitivity in acute myelogenous leukemia cell line by GM-CSF: opposing effects observed with different cytotoxic drugs and time exposure.
    Ciaiolo C, Ferrero D, Pugliese A, Ortolano B, Borrione P, Pileri A.
    Leuk Res; 1999 Oct 10; 23(10):931-8. PubMed ID: 10573139
    [Abstract] [Full Text] [Related]

  • 11. Cystathionine-beta-synthase cDNA transfection alters the sensitivity and metabolism of 1-beta-D-arabinofuranosylcytosine in CCRF-CEM leukemia cells in vitro and in vivo: a model of leukemia in Down syndrome.
    Taub JW, Huang X, Ge Y, Dutcher JA, Stout ML, Mohammad RM, Ravindranath Y, Matherly LH.
    Cancer Res; 2000 Nov 15; 60(22):6421-6. PubMed ID: 11103808
    [Abstract] [Full Text] [Related]

  • 12. FLT3-ITD induces ara-C resistance in myeloid leukemic cells through the repression of the ENT1 expression.
    Jin G, Matsushita H, Asai S, Tsukamoto H, Ono R, Nosaka T, Yahata T, Takahashi S, Miyachi H.
    Biochem Biophys Res Commun; 2009 Dec 18; 390(3):1001-6. PubMed ID: 19853583
    [Abstract] [Full Text] [Related]

  • 13. Drastic effect of cell density on the cytotoxicity of daunorubicin and cytosine arabinoside.
    Masquelier M, Vitols S.
    Biochem Pharmacol; 2004 May 01; 67(9):1639-46. PubMed ID: 15081863
    [Abstract] [Full Text] [Related]

  • 14. All- trans-retinoic acid increases cytotoxicity of 1-beta-D-arabinofuranosylcytosine in NB4 cells.
    Flanagan SA, Meckling KA.
    Cancer Chemother Pharmacol; 2003 May 01; 51(5):363-75. PubMed ID: 12736759
    [Abstract] [Full Text] [Related]

  • 15. Generation of reactive oxygen intermediates after treatment of blasts of acute myeloblastic leukemia with cytosine arabinoside: role of bcl-2.
    Hedley DW, McCulloch EA.
    Leukemia; 1996 Jul 01; 10(7):1143-9. PubMed ID: 8683994
    [Abstract] [Full Text] [Related]

  • 16. Characterization of resistance to cytosine arabinoside (Ara-C) in NALM-6 human B leukemia cells.
    Kanno S, Hiura T, Ohtake T, Koiwai K, Suzuki H, Ujibe M, Ishikawa M.
    Clin Chim Acta; 2007 Feb 01; 377(1-2):144-9. PubMed ID: 17097625
    [Abstract] [Full Text] [Related]

  • 17. The effect of G-CSF on the in vitro cytotoxicity of cytarabine and fludarabine in the FLAG combination in pediatric acute myeloid leukemia.
    Hubeek I, Litvinova E, Peters GJ, Broekhuizen R, Haarman EG, Huismans DR, Cloos J, Zwaan CM, Fleischhack G, Creutzig U, Kaspers GJ.
    Int J Oncol; 2004 Dec 01; 25(6):1823-9. PubMed ID: 15547723
    [Abstract] [Full Text] [Related]

  • 18. Effect of stem cell factor on leukemic progenitor cell growth and sensitivity to cytosine-arabinoside.
    Viallard JF, Grosset C, Lacombe F, David S, Mahon FX, Barbot C, Vianes I, Dupouy M, Reiffers J.
    Leuk Res; 1996 Dec 01; 20(11-12):915-23. PubMed ID: 9009249
    [Abstract] [Full Text] [Related]

  • 19. Bortezomib activity and in vitro interactions with anthracyclines and cytarabine in acute myeloid leukemia cells are independent of multidrug resistance mechanisms and p53 status.
    Minderman H, Zhou Y, O'Loughlin KL, Baer MR.
    Cancer Chemother Pharmacol; 2007 Jul 01; 60(2):245-55. PubMed ID: 17096161
    [Abstract] [Full Text] [Related]

  • 20. Anti-CD33 monoclonal antibodies enhance the cytotoxic effects of cytosine arabinoside and idarubicin on acute myeloid leukemia cells through similarities in their signaling pathways.
    Balaian L, Ball ED.
    Exp Hematol; 2005 Feb 01; 33(2):199-211. PubMed ID: 15676214
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.